Antiviral treatment for hepatitis B virus recurrence following liver transplantation

Clinical Transplantation

Volumn 27, Issue 5, 2013, Pages

  Lee, Sanghoon ^a   Kwon, Choon Hyuck D ^a   Moon, Hyung Hwan ^a   Kim, Tae Seok ^a   Roh, Youngnam ^a   Song, Sanghyun ^a   Shin, Milljae ^a   Kim, Jong Man ^a   Park, Jae Berm ^a   Kim, Sung Joo ^a   Joh, Jae Won ^a   Lee, Suk Koo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Antiviral therapy; HBV recurrence; Hepatitis B virus; Liver transplantation

Indexed keywords

ADEFOVIR; CORTICOSTEROID; CYCLOSPORIN; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOSIDE ANALOG; TACROLIMUS; TENOFOVIR; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; EXPLANT; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; SEROLOGY; SURVIVAL; TREATMENT OUTCOME; VIRAL CLEARANCE; VIRUS LOAD;

ANTIVIRAL THERAPY; HBV RECURRENCE; HEPATITIS B VIRUS; LIVER TRANSPLANTATION;

ADULT; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GUANINE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MEDICAL RECORDS; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84884963627     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12212     Document Type: Article

References (18)

1. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002: 8: 765.
2. Papatheodoridis GV, Sevastianos V, Burroughs AK. Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era. Am J Transplant 2003: 3: 250.
3. Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1842: 1993: 329.
4. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991: 13: 619.
5. Perrillo R, Rakela J, Dienstag J et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology 1999: 29: 1581.
6. Fontana RJ, Hann HW, Wright T et al. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Liver Transpl 2001: 7: 504.
7. Saab S, Yeganeh M, Nguyen K et al. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl 2009: 15: 1525.
8. EASL. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009: 50: 227.
9. Zoulim F, Locarnini S. Management of treatment failure in chronic hepatitis B. J Hepatol 2012: 56(Suppl 1): S112.
10. Chun J, Kim W, Kim BG et al. High viremia, prolonged lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence. Am J Transplant 2010: 10: 1649.
11. Steinmuller T, Seehofer D, Rayes N et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002: 35: 1528.
12. Markowitz JS, Martin P, Conrad AJ et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998: 28: 585.
13. Degertekin B, Han SH, Keeffe EB et al. Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant 1823: 2010: 10.
14. Hwang S, Ahn CS, Song GW et al. Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on. Liver Transpl 2011: 17: 456.
15. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 2011: 34: 1145.
16. Faria LC, Gigou M, Roque-Afonso AM et al. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 1890: 2008: 134.
17. Kim HS, Lee J, Yi SY et al. Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer 2009: 9: 205.
18. Koda M, Nagahara T, Matono T et al. Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function. Intern Med 2009: 48: 11.